Amanote Research
Register
Sign In
Estimating Utilities / Disutilities for High Risk Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) and Treatment-Related Adverse Events
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.282
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
F Hall
HM de Freitas
C Kerr
T Ito
B Nafees
AJ Lloyd
J Penton
M Hadi
T Pham
Publisher
Elsevier BV
Related search
Chemohormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer: An Asian Perspective
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer
Cancer Discovery
Oncology
Combined Chemohormonalradiation Treatment of Highand Very-High-Risk Non-Metastatic Prostate Cancer
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
New Possibilities of Combined Antiandrogen Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Abiraterone Acetate and Docetaxel With Androgen Deprivation Therapy in High-Volume Metastatic Hormone-Sensitive Prostate Cancer in China: An Indirect Treatment Comparison and Cost Analysis
Cost Effectiveness and Resource Allocation
Health Policy
Pcn341 - Estimation of Utilities on Skeletal-Related Events (Sre) in Patients With Bone Metastatic Cancer in Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tibolone and Risk of Gynecological Hormone Sensitive Cancer
International Journal of Cancer
Cancer Research
Oncology
